Avantor stock, healthcare

Avantor stock falls 1.20 percent as new CFO takes office

Published on 09/24/2026 at 15:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Avantor stock stood at USD 14.76 on September 23, 2026, 8.0 percent below its 52-week high. Q2 revenue reached USD 1.6923 billion, up 0.5 percent year over year.

Avantor stock,  healthcare,  medical instruments and supplies,  CFO change,  NYSE, Illustration mit AI erstellt.
Avantor stock, healthcare, medical instruments and supplies, CFO change, NYSE, Illustration mit AI erstellt.

Avantor stock fell 1.20 percent to USD 14.76 on the NYSE on September 23, 2026, leaving the shares 8.0 percent below their 52-week high of USD 16.05. The move came as the life-sciences supplier began a finance leadership transition announced for September 21, 2026.

New CFO starts September 21

RTT News reported that Todd Garner became Avantor's executive vice president and chief financial officer on September 21, 2026. He joined from CONMED, where he had served as executive vice president and CFO from 2018 to 2026.

The appointment follows a second quarter in which Avantor generated USD 1.6923 billion of revenue, up 0.5 percent from USD 1.6834 billion in the year-earlier quarter. The comparison shows a modest top-line recovery, but earnings remain more demanding for the company than sales growth alone suggests.

VWR growth offsets BMP pressure

According to the Globe and Mail, adjusted EBITDA was USD 254 million in Q2 2026, equal to a 15 percent margin, while adjusted EPS was USD 0.21. VWR Distribution and Services delivered 1.7 percent organic revenue growth, whereas Bioscience and Medtech Products revenue declined 5.6 percent organically.

The contrast between the two segments is central to the investment case. VWR's return to organic growth supports the recovery narrative, while the BMP decline and margin pressure limit the immediate earnings effect of stronger distribution volumes.

Guidance points to a narrow recovery

RTT News reported that Avantor lifted its fiscal 2026 organic revenue guidance to negative 0.5 percent to positive 0.5 percent and raised adjusted EPS guidance to USD 0.80 to USD 0.83 from USD 0.77 to USD 0.83. The revised range is wider than a simple growth story, because it still allows for a slight annual decline.

Stock stays below yearly high

Avantor's market capitalization was USD 9,983,058,840 as of September 23, 2026. The stock's 52-week range was USD 7.26 to USD 16.05, placing the latest price at USD 14.76 and 8.0 percent below the upper end of that range.

Avantor company facts

  • Company: Avantor, Inc.
  • Ticker: AVTR
  • Trading venue: NYSE
  • Price as of September 23, 2026: USD 14.76
  • Market capitalization: USD 9,983,058,840 as of September 23, 2026
  • 52-week range: USD 7.26-16.05
  • Sector / Industry: Healthcare / Medical Instruments and Supplies

Disclaimer...

en | boerse | 70177833 |